Ascend Q4 Revenue Increases 25% – New Cannabis Ventures

Mar 12, 2024 · AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS. Q4 2023 Net Revenue Increased 25% Year-over-Year to $140 million Q4 2023 …

25%
OFF

Ascend Q4 Revenue Increases 25% – New Cannabis Ventures

1 week from now

Mar 12, 2024 · AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS. Q4 2023 Net Revenue Increased 25% Year-over-Year to $140 million Q4 2023 …

newcannabisventures.com

3%
OFF

News Release Details - Ascend Wellness Holdings

1 week from now

Mar 12, 2024 · FY 2023: Total revenue of $635.2 million increased 30.3% year-over-year. Q4 2023: Net revenue, which excludes intercompany sale of wholesale products, decreased 0.8% …

awholdings.com

25%
OFF

Ascend Wellness Holdings Inc (AAWH) Reports Strong Fiscal Year …

1 week from now

Ascend Wellness Holdings Inc (AAWH) Reports Strong Fiscal Year 2023 Results with Revenue and ... Net Revenue: Q4 2023 net revenue increased by 25% year-over-year to $140 million, …

yahoo.com

6%
OFF

Cannabis Acquisitions Pay Off: MSO Ascend Wellness Q4 Revenue …

1 week from now

Mar 12, 2024 · Net loss of $19.3 million compared to net loss of $15.1 million in Q4 2022. Adjusted EBITDA was $32.4 million, a 9.6% increase quarter-over-quarter and a 14.8% …

benzinga.com

$141
OFF

Ascend Wellness Q3 Revenue Was Flat – New Cannabis Ventures

1 week from now

3 days ago · Achieved $141.6 million Net Revenue in Q3 2024 Reported $25.1 million in Adjusted EBITDA Anticipates $30 million of Annual Savings Through Transformation Initiatives …

newcannabisventures.com

28%
OFF

Ascend Wellness Releases Fourth Quarter, Full Year 2023 Financial ...

1 week from now

Mar 12, 2024 · The multistate cannabis operator reported $519 million in net revenue for the year, representing a 28% increase over 2022. ... Q4 2023 Net Revenue Increased 25% Year-over …

cannabisbusinesstimes.com

$5
OFF

Another Quarter Of Weak Revenue Growth For Cannabis Companies

1 week from now

12 hours ago · As the industry has scaled and as more companies have gone public, we have raised the minimum several times subsequently, including a move to US$5 million in October …

newcannabisventures.com

8%
OFF

Ascend Wellness Is A Fantastic Opportunity For Cannabis Investors

1 week from now

Jul 22, 2024 · The New Cannabis Ventures American Cannabis Operator Index has dropped 1.8%. There is one Tier 2 name that is up, Ayr Wellness (OTCQX:AYRWF), and the other two …

seekingalpha.com

60%
OFF

Agrify Q4 Revenue Increases 60% Sequentially To $25.3 Million

1 week from now

Mar 23, 2022 · Agrify Announces Record Fourth Quarter and Fiscal Year 2021 Results. 2021 Revenue Increased 395% Year-Over-Year to $59.9 Million Fourth Quarter Revenue Increased …

newcannabisventures.com

$800
OFF

Celebrating Three Years Of Growth And Equity In NJ Cannabis

1 week from now

Apr 22, 2024 · In 2023, New Jersey saw cannabis sales of more than $800 million. With new local cultivators and manufacturers beginning operations, we expect to reach $1 billion in 2024. …

nj.gov

4%
OFF

TerrAscend Q4 Revenue Increases 4% Sequentially - New Cannabis …

1 week from now

Dec 31, 2022 · Fourth Quarter 2022 Financial Highlights. Net Revenue was $69.0 million, an increase of 4.2% sequentially and 50.3% year-over-year. G ross Profit Margin was 44.6%, …

newcannabisventures.com

$5
OFF

Cannabis Earnings Season Is About To Begin – New Cannabis …

1 week from now

Oct 30, 2024 · As the industry has scaled and as more companies have gone public, we have raised the minimum several times subsequently, including a move to US$5 million in October …

newcannabisventures.com

FAQs about Ascend Q4 Revenue Increases 25% – New Cannabis Ventures Coupon?

Does ascend wellness have a good outlook for 2024 & 2025?

Ascend Wellness's outlook has improved with strong Q1 results, increasing revenue, and adjusted EBITDA projections for 2024 and 2025. The Company extended its debt due in 2025, securing lenders, and closing a deal with a maturity date of 2029. ...

How will revenue grow in 2024?

For 2024, a single analyst is projecting that revenue will expand 13% to $588.3 million. The adjusted EBITDA is expected to increase 18% to $126.4 million, a margin of 21.5%. In its Q1 press release, the company guided to revenue growth of 12-15% in 2024 with adjusted EBITDA growth of 17-22%. ...

How did aawh perform in Q4?

AAWH reported positive cash from operations and free cash flow in Q4, ending the year with $73 million in cash and cash equivalents. In third-party markets, retail revenue increased by 21% and wholesale revenue by 47%, contributing to the strong performance in Q4 of their fiscal year 2023. ...

How did Q1 perform in 2024?

In its Q1 press release, the company guided to revenue growth of 12-15% in 2024 with adjusted EBITDA growth of 17-22%. It also guided to cash flow from operations for the year of $55-65 million. In its 10-Q, it projected additional capital expenditures of $35-40 million during the year. ...

Is ascend a good stock to buy?

Ascend offers significant upside potential, though it along with other cannabis stocks face a risk of rescheduling not taking place. Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks. ...

Could a rescheduling of cannabis benefit aawh?

The potential rescheduling of cannabis and the elimination of the 280E tax could benefit AAWH, making it a very inexpensive investment opportunity with significant upside potential. Looking for a portfolio of ideas like this one? Members of 420 Investor get exclusive access to our subscriber-only portfolios. Learn More » ...